Allogenic juvenile chondrocytes (Isto Biologics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAllogenic juvenile chondrocytes (Isto Biologics)
Drug Alias NameChondrocyte disc regeneration therapy (Isto Biologics)NuQu
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Somatic cell > Cartilage cell therapy
Mechanisms of ActionCartilage replacements
TargetsNot applicable
Therapy Area/IndicationsIntervertebral disc disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIsto Biologics
China Registration ClassN/A

Develop Information

Active CompaniesIsto Biologics
Inactive CompaniesN/A
Active IndicationsIntervertebral disc disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A